Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 796

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 796
---
2024, there was $ 224 in unrecognized compensation expense that will be recognized over the next 1.8 years.

The following table sets forth changes in unvested stock options under all plans:

| Unvested at June 30, 2024      |     | Number ofOptions(in thousands) |  3 |   |     | Weightedaverageexerciseprice$ | 545.01 |
|:-------------------------------|:----|:-------------------------------|---:|:--|:----|:------------------------------|-------:|
| Vested                         |     |                                | (1 | ) |     |                               | 435.36 |
| Unvested at September 30, 2024 |     |                                |  2 |   |     |                               | 579.79 |

The aggregate intrinsic value of unvested stock options at September 30, 2024, was nil (2023 - nil ). The unvested stock options have a remaining weighted average contractual term of 7.16 years (2023 - 9.26 ).

Restricted stock units

During the three months ended September 30, 2024, the Company recognized a total of $ 3 (2023 - $ 47 ) in compensation expense related to RSUs.

| Balance - June 30, 2024           |     | Number ofRSU(in thousands) | 2  |   |
|:----------------------------------|:----|:---------------------------|:---|:--|
| Vesting of restricted stock units |     |                            | (2 | ) |
| Balance - September 30, 2024      |     |                            | —  |   |

Common stock warrants

The following table sets forth changes in outstanding common stock warrants:

|                                        |     | Number ofWarrants(in thousands) |    |   |     | Weightedaverageexerciseprice$ |          |
| Balance - June 30, 2024                |     |                                 | 19 |   |     |                               | 1,399.72 |
| Expiry of warrants issued for services |     |                                 | (2 | ) |     |                               | 1,750.00 |
| Balance - September 30, 2024           |     |                                 | 17 |   |     |                               | 1,362.41 |

The following table summarizes the Company’s outstanding common stock warrants as of September 30, 2024:

| Description of warrants      
 202